Serum antibodies to enterohepatic Helicobacter spp. in patients with chronic liver diseases and in a population with high prevalence of H-pylori infection

被引:26
|
作者
Vorobjova, T
Nilsson, I
Terjajev, S
Granholm, M
Lyyra, M
Porkka, T
Prükk, T
Salupere, R
Maaroos, HI
Wadström, T
Uibo, R
机构
[1] Univ Tartu, Inst Gen & Mol Pathol, Ctr Mol & Clin Med, Dept Immunol, EE-51014 Tartu, Estonia
[2] Lund Univ, Div Med Microbiol, Dept Lab Med, S-22100 Lund, Sweden
[3] Univ Tartu, Dept Internal Med, Div Infect Dis, Tartu, Estonia
[4] Univ Tartu, Dept Internal Med, Div Gastroenterol, Tartu, Estonia
[5] Univ Tartu, Dept Family Med, Tartu, Estonia
关键词
chronic liver diseases; H; bilis; hepaticus; pullorum; pylori; population; serum antibodies;
D O I
10.1016/j.dld.2005.12.008
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background. Enteric Helicobacter species might be a risk factor for chronic liver and biliary tract diseases. Aims. To analyse serum antibody levels to three enteric Helicobacter species in patients with various biliary tract and chronic liver diseases and compare results with corresponding parameters for an adult population group, known to have a high prevalence of Helicobacter pylori infection, and with healthy blood donors, to explore a possible association of enteric Helicobacter with chronic liver diseases. Subjects. Sera of 90 patients with various chronic liver diseases, 121 Estonian adult persons and 68 blood donors were analysed. Methods. Sera, previously tested for H. pylori were analysed for IgG to Helicobacter hepaticus, Helicobacter bilis and Helicobacter pullorum. ELISA was initially used for screening and exclusion of negative cases. Sera with positive ELISA results were further analysed by immunoblot. To remove cross-reactive antibodies between H. pylori and the enteric species, sera were pre-absorbed with lysed H. pylori cells. Results. Liver patients showed a significantly higher seroprevalence to H. hepaticus and H. bilis, compared with the adult population group (p = 0.0001 and 0.04, respectively), and to H. hepaticus, compared with blood donors (p = 0.01). Patients with autoimmune hepatitis showed no significant antibody reactivity to the enteric Helicobacter spp. in contrast to patients with other chronic liver diseases. Conclusion. Patients with chronic liver diseases, except autoimmune hepatitis patients, showed increased antibody levels to H. bilis/H. hepaticus compared with the population and blood donors indicating a possible role of enteric Helicobacter in the natural course of chronic liver diseases. Immunoblot seems to be a promising method for serodiagnosis of infections with these fastidious pathogens. (C) 2005 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:171 / 176
页数:6
相关论文
共 50 条
  • [1] Serum antibodies to Helicobacter hepaticus, Helicobacter bilis, and Helicobacter pullorum in patients with chronic liver diseases and in a population with high prevalence of Helicobacter pylori infection
    Vorobjova, T
    Nilsson, I
    Terjajev, S
    Granholm, M
    Lyyra, M
    Porkka, T
    Prükk, T
    Salupere, R
    Maaroos, HI
    Wadström, T
    Uibo, R
    [J]. HELICOBACTER, 2005, 10 (05) : 551 - 551
  • [2] Helicobacter spp. infection and chronic liver diseases
    Biernat, Monika
    Gosciniak, Grazyna
    Simon, Krzysztof
    Knysz, Brygida
    Rotter, Katarzyna
    Grabinska, Joanna
    Fleischer, Katarzyna
    [J]. ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2007, 16 (04): : 537 - 542
  • [3] The prevalence of Helicobacter pylori (H-pylori) infection and peptic ulcer in diabetic patients
    Moriai, T
    Okamoto, S
    Chisaka, K
    Morita, Y
    Hirahara, N
    [J]. GASTROENTEROLOGY, 1999, 116 (04) : A259 - A259
  • [4] Is Helicobacter pylori-negative duodenal ulcer masked by the high prevalence of H-pylori infection in the general population?
    Higuchi, K
    Arakawa, T
    Fujiwara, Y
    Uchida, T
    Tominaga, K
    Watanabe, T
    Kuroki, T
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 1999, 94 (10): : 3083 - 3084
  • [5] Prevalence of serum antibodies to Helicobacter pylori in patients with rheumatic diseases.
    de Leest, HTJI
    Wijngaarden, S
    Steen, KSS
    Lems, WF
    de Koning, MHMT
    Van der Stadt, RJ
    Blaauw, AAM
    Debets, YJ
    Bijlsma, JW
    Boers, M
    Dijkmans, BAC
    [J]. ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S137 - S137
  • [6] PREVALENCE AND CHARACTERIZATION OF HELICOBACTER PYLORI (H-PYLORI) INFECTION AND COLONIZATION IN DENTISTS
    Loster, B. W.
    Czesnikiewicz-Guzik, M.
    Bielanski, W.
    Karczewska, E.
    Loster, J. E.
    Kalukin, J.
    Guzik, T. J.
    Majewski, S.
    Kontsurek, S. J.
    [J]. JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2009, 60 : 13 - 18
  • [7] Serum antibodies to Helicobacter hepaticus and Helicobacter pylori in patients with chronic liver disease
    Nilsson, I
    Lindgren, S
    Eriksson, S
    Wadström, T
    [J]. GUT, 2000, 46 (03) : 410 - 414
  • [8] HIGH PREVALENCE OF ENTEROHEPATIC HELICOBACTER SPP. IN AGED MACAQUES WITH INTESTINAL ADENOCARCINOMA
    Lertpiriyapong, K.
    Handt, L. K.
    Shen, Z.
    Michael, T. W.
    Lodge, K.
    Fox, J. G.
    [J]. HELICOBACTER, 2011, 16 : 139 - 139
  • [9] High Prevalence of Enterohepatic Helicobacter spp. in Aged Macaques with Intestinal Adenocarcinoma
    Lertpiriyapong, K.
    Handt, L. K.
    Shen, Z.
    Mitchell, T. W.
    Lodge, K.
    Fox, J. G.
    [J]. JOURNAL OF THE AMERICAN ASSOCIATION FOR LABORATORY ANIMAL SCIENCE, 2011, 50 (05): : 725 - 726
  • [10] Helicobacter pylori infection and autoimmune diseases:: Prevalence of infection in patients with Hashimoto's thyroiditis and alignment of thyroid hormones with H-pylori proteins
    Figura, N
    Di Cairano, G
    Santucci, A
    Lenzi, C
    Gonnelli, C
    Campagna, S
    Franci, B
    Lucani, B
    Kristodhullu, S
    Nuti, R
    Pacini, F
    [J]. HELICOBACTER, 2005, 10 (05) : 513 - 513